Growth Factor (VEGF) Antibodies
Market, Global Outlook and Forecast 2022-
2028 Market
Vascular Endothelial Growth Factor (VEGF)
Antibodies Market, Global Outlook and Forecast
2022-2028 Market Scope: Industry Analysis, Market
Size, Growth, Trends Till 2031
Request Sample Report
Vascular Endothelial Growth Factor (VEGF) Antibodies
Market, Global Outlook and Forecast 2022-2028
Market Size and Growth
The global Vascular Endothelial Growth Factor (VEGF) Antibodies market is projected to grow at a CAGR of 7.5% from 2022 to 2028. Increasing prevalence of cancer and vascular diseases, coupled with advancements in biotechnology, are driving market growth. The market size is estimated to reach $2.1 billion by 2028.
Companies Covered
(Covid 19 Impact Covered)
◍ Roche
◍ Novartis
◍ Sanofi
◍ Regeneron
◍ Bayer
◍ AstraZeneca
◍ Pfizer
◍ Merck
◍ Eli Lilly
◍ GlaxoSmithKline
◍ Bristol-Myer Squibb
◍ Boehringer Ingelheim
◍ Abcam Plc
The global Vascular Endothelial Growth Factor (VEGF) Antibodies market is highly competitive with key players such as Roche, Novartis, Sanofi, Regeneron, and Bayer. These companies utilize VEGF antibodies for the treatment of various diseases such as cancer, macular degeneration, and diabetic retinopathy, driving market growth.
- Roche: $61.61 billion
- Novartis: $48.66 billion
- Sanofi: $37.06 billion
Request Sample Report
Market Segmentation
By Application
◍ Hospitals
◍ Specialty Clinics
◍ Ambulatory Surgical Centers
◍ Cancer Research Institutes
◍ Others
By Product
◍ Bevacizumab
◍ Ranibizumab
◍ Aflibercept
◍ Others
Request Sample Report
Market Growth
Request Sample Report
$ X Billion USD
